instruction stringlengths 225 2.35k | input stringlengths 89 1.5k | response stringclasses 698 values |
|---|---|---|
<Instruct>: Given the context 'To further evaluate the host TNF-α response during an established B. mallei chronic infection, we infected 12 BALB/c mice by the i.p. route with 1 × 106 CFU B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; mice]
<Options>: A: mallomonas papillosa
B: mus sp. (mice (aka mus sp.))
C: pseudomonas mallei (aka burkholderia mallei)
D: modicella malleola (endogone malleola) (aka modicella malleola)
E: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
F: 'bartonella melophagi' (aka bartonella melophagi)
G: mus castaneus (aka mus musculus castaneus)
H: mus cricetus (aka cricetus cricetus)
I: mus domesticus (aka mus musculus domesticus)
J: mouse (aka mus musculus)
K: None of the above. | [C; J] |
<Instruct>: Given the context 'To further evaluate the host TNF-α response during an established B. mallei chronic infection, we infected 12 BALB/c mice by the i.p. route with 1 × 106 CFU B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; mice]
<Options>: A: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
B: mallomonas papillosa
C: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
D: mus castaneus (aka mus musculus castaneus)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: mus <subgenus> (mus (aka mus <subgenus>))
G: mus cricetus (aka cricetus cricetus)
H: mus musculus (house mouse) (aka mus musculus)
I: malleco
J: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
K: None of the above. | [A; H] |
<Instruct>: Given the context 'On day 42 post-infection, the remaining 11 mice were dosed with either anti-TNF-α (n = 6), or control mAb (AFRC Mac 49) (n = 5).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: house mouse (aka mus musculus)
B: mus castaneus (aka mus musculus castaneus)
C: mus sp. (mice (aka mus sp.))
D: mus cricetus (aka cricetus cricetus)
E: eastern european house mouse (aka mus musculus musculus)
F: None of the above. | [A] |
<Instruct>: Given the context 'No further deaths were observed in the control mAb-treated mice.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: peromyscus
B: mus <subgenus> (mus (aka mus <subgenus>))
C: mus castaneus (aka mus musculus castaneus)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: mus musculus (house mouse) (aka mus musculus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Rapid mortality was observed in the anti-TNF-α-treated group, with all mice dying within 7 days of treatment (p = 0.0023) relative to the isotype-treated controls (Fig. 5).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
B: mouse (aka mus musculus)
C: mus cricetus (aka cricetus cricetus)
D: mus sp. (mice (aka mus sp.))
E: mice (aka mus <genus>) (aka mus <genus>)
F: None of the above. | [B] |
<Instruct>: Given the context 'J774A.1 uptake of serum treated B. mallei
Complement mediated uptake assays were performed to evaluate opsonization.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: pfeifferella mallei (aka burkholderia mallei)
B: malleomyces pseudomallei (aka burkholderia pseudomallei)
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: erysiphe malloti
E: mallomonas peronoides (aka mallomonas peroneides)
F: None of the above. | [A] |
<Instruct>: Given the context 'Results indicated enhanced bacterial uptake in J774A.1 phagocytes inoculated with serum treated B. mallei (p = .0082), compared to B. mallei alone, while heat-inactivated serum produced uptake percentages similar to those prior to serum addition (Fig. 6).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallomonas papillosa
B: inocybe subg. mallocybe (aka mallocybe)
C: actinobacillus mallei (aka burkholderia mallei)
D: mallomonas peronoides (aka mallomonas peroneides)
E: 'bartonella melophagi' (aka bartonella melophagi)
F: None of the above. | [C] |
<Instruct>: Given the context 'Immunoglobulin production in HK vaccinated BALB/c mice
We further characterized the ability of HK vaccination to induce a predominant IgG isotype by determining IgG2a/IgG1 ratios in i.p. and i.n. vaccinated BALB/c mice.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mouse (aka mus musculus)
C: peromyscus
D: mus (aka mus <subgenus>) (aka mus <subgenus>)
E: eastern european house mouse (aka mus musculus musculus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: loefflerella pseudomallei (aka burkholderia pseudomallei)
B: western european house mouse (aka mus musculus domesticus)
C: mice (aka mus sp.) (aka mus sp.)
D: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
E: peromyscus
F: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
G: erysiphe malloti
H: mallomonas peronoides (aka mallomonas peroneides)
I: 'bartonella melophagi' (aka bartonella melophagi)
J: mus musculus (house mouse) (aka mus musculus)
K: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
L: modicella malleola (endogone malleola) (aka modicella malleola)
M: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
N: burkholderia pseudomallei 5(1949)
O: mus castaneus (aka mus musculus castaneus)
P: None of the above. | [J; D; A] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: burkholderia pseudomallei 5(1949)
B: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
C: mice (aka mus sp.) (aka mus sp.)
D: loefflerella pseudomallei (aka burkholderia pseudomallei)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
G: 'bartonella melophagi' (aka bartonella melophagi)
H: peromyscus
I: erysiphe malloti
J: mus castaneus (aka mus musculus castaneus)
K: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
L: mallomonas peronoides (aka mallomonas peroneides)
M: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
N: western european house mouse (aka mus musculus domesticus)
O: None of the above. | [O; B; D] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: burkholderia pseudomallei bdu 2
D: peromyscus
E: loefflerella pseudomallei (aka burkholderia pseudomallei)
F: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
G: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
H: house mouse (aka mus musculus)
I: malleomyces pseudomallei (aka burkholderia pseudomallei)
J: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
K: mus <genus> (mice (aka mus <genus>))
L: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
M: eastern european house mouse (aka mus musculus musculus)
N: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
O: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
P: None of the above. | [H; O; E] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: modicella malleola (endogone malleola) (aka modicella malleola)
B: mus musculus (house mouse) (aka mus musculus)
C: malleco
D: bacillus pseudomallei (aka burkholderia pseudomallei)
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: mus <subgenus> (mus (aka mus <subgenus>))
G: mus castaneus (aka mus musculus castaneus)
H: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
I: mucilaginibacter mallensis
J: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
K: peromyscus
L: burkholderia pseudomallei bdu 2
M: pseudomonas mallei (aka burkholderia mallei)
N: burkholderia pseudomallei 5(1949)
O: malleomyces pseudomallei (aka burkholderia pseudomallei)
P: None of the above. | [B; M; D] |
<Instruct>: Given the context 'A similar protective role in the innate response to infection has been demonstrated for TNF-α in B. pseudomallei infection [8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
B: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
C: bacillus pseudomallei (aka burkholderia pseudomallei)
D: burkholderia pseudomallei bdu 2
E: burkholderia pseudomallei 5(1949)
F: None of the above. | [C] |
<Instruct>: Given the context 'The studies presented here are consistent with the essential role of these factors in the relative levels of protection conferred by vaccination with heat-killed B. pseudomallei and would appear to be viable early markers for protection from lethal acute infection [9].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei bdu 2
B: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
C: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
F: None of the above. | [D] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: mouse (aka mus musculus)
B: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
C: peromyscus
D: pseudomonas pseudomallei (aka burkholderia pseudomallei)
E: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
F: mucilaginibacter mallensis
G: malleomyces pseudomallei (aka burkholderia pseudomallei)
H: mus norvegicus (aka rattus norvegicus)
I: pfeifferella mallei (aka burkholderia mallei)
J: mus <subgenus> (mus (aka mus <subgenus>))
K: inocybe subg. mallocybe (aka mallocybe)
L: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
M: burkholderia pseudomallei 6(1960)
N: pseudomallei group
O: erysiphe malloti
P: None of the above. | [I; D; A] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: malleco
B: pseudomonas pseudomallei (aka burkholderia pseudomallei)
C: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
D: mus cricetus (aka cricetus cricetus)
E: burkholderia pseudomallei strain cb (aka burkholderia pseudomallei cb)
F: mouse (aka mus musculus)
G: burkholderia pseudomallei 5(1949)
H: mallomonas papillosa
I: burkholderia pseudomallei bdu 2
J: mice (aka mus sp.) (aka mus sp.)
K: modicella malleola (endogone malleola) (aka modicella malleola)
L: 'bartonella melophagi' (aka bartonella melophagi)
M: western european house mouse (aka mus musculus domesticus)
N: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
O: loefferella mallei (aka burkholderia mallei)
P: None of the above. | [O; B; F] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: bacterium whitmori (aka burkholderia pseudomallei)
B: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
C: mucilaginibacter mallensis
D: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: mus cricetus (aka cricetus cricetus)
G: burkholderia pseudomallei 6(1960)
H: pseudomallei group
I: malleomyces pseudomallei (aka burkholderia pseudomallei)
J: acinetobacter mallei (aka burkholderia mallei)
K: mallomonas peronoides (aka mallomonas peroneides)
L: mus musculus (house mouse) (aka mus musculus)
M: mus sp. (mice (aka mus sp.))
N: peromyscus
O: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
P: None of the above. | [J; A; L] |
<Instruct>: Given the context 'Previous studies have also demonstrated that both the humoral and cell-mediated arms are essential for protection from B. pseudomallei infection [10].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: pseudomallei group
B: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
C: burkholderia pseudomallei 5(1949)
D: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
E: pseudomonas pseudomallei (aka burkholderia pseudomallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Thus, loss or reduction of TNF-α and IFN-γ levels result in significantly reduced survival rates, substantiating previous reports of the role of these factors in protection against B. mallei [7].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: inocybe subg. mallocybe (aka mallocybe)
B: erysiphe malloti
C: pfeifferella mallei (aka burkholderia mallei)
D: modicella malleola (endogone malleola) (aka modicella malleola)
E: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
F: None of the above. | [C] |
<Instruct>: Given the context 'Moreover, we demonstrate a role for sustained TNF-α production in the maintenance of host survival throughout the course of B. mallei infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
C: mucilaginibacter mallensis
D: acinetobacter mallei (aka burkholderia mallei)
E: mallomonas papillosa
F: None of the above. | [D] |
<Instruct>: Given the context 'Moreover, we demonstrate a role for sustained TNF-α production in the maintenance of host survival throughout the course of B. mallei infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mucilaginibacter mallensis
B: malleomyces pseudomallei (aka burkholderia pseudomallei)
C: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
D: mallomonas papillosa
E: None of the above. | [E] |
<Instruct>: Given the context 'Mice with an established B. mallei chronic infection rapidly lost the ability to control the growth of the bacillus upon neutralization of TNF-α.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: house mouse (aka mus musculus)
C: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
D: mus castaneus (aka mus musculus castaneus)
E: loefferella mallei (aka burkholderia mallei)
F: modicella malleola (endogone malleola) (aka modicella malleola)
G: mouse (aka mus <genus>)
H: mus cricetus (aka cricetus cricetus)
I: mallomonas papillosa
J: mucilaginibacter mallensis
K: None of the above. | [B; E] |
<Instruct>: Given the context 'Mice with an established B. mallei chronic infection rapidly lost the ability to control the growth of the bacillus upon neutralization of TNF-α.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: inocybe subg. mallocybe (aka mallocybe)
C: eastern european house mouse (aka mus musculus musculus)
D: mus cricetus (aka cricetus cricetus)
E: mouse (aka mus musculus)
F: malleco
G: acinetobacter mallei (aka burkholderia mallei)
H: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
I: mallomonas papillosa
J: western european house mouse (aka mus musculus domesticus)
K: None of the above. | [E; G] |
<Instruct>: Given the context 'Additional studies are underway to determine more precisely the role of TNF-α in host protection to B. mallei.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: inocybe subg. mallocybe (aka mallocybe)
B: acinetobacter mallei (aka burkholderia mallei)
C: malleco
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
F: None of the above. | [B] |
<Instruct>: Given the context 'Multiple innate and adaptive cell types may contribute to the production of IFN-γ in response to infection with B. mallei following vaccination.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: bacillus mallei (aka burkholderia mallei)
C: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
D: mallomonas papillosa
E: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
F: None of the above. | [B] |
<Instruct>: Given the context 'The effector role for IFN-γ in mediating protection against B. mallei may include both immunoregulatory and non-regulatory functions.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: erysiphe malloti
D: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
E: malleomyces pseudomallei (aka burkholderia pseudomallei)
F: None of the above. | [A] |
<Instruct>: Given the context 'Regardless, the requirement of IFN-γ, as demonstrated by administration of neutralizing antibody prior to infection, indicates that stimulation of IFN-γ response is a desirable goal for a B. mallei vaccine.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallomonas peronoides (aka mallomonas peroneides)
B: malleco
C: mallomonas papillosa
D: mucilaginibacter mallensis
E: bacillus mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Similarly, B220-positive cells appear to play a role in protection following vaccination with heat-killed B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: erysiphe malloti
B: pseudomonas mallei (aka burkholderia mallei)
C: mallomonas papillosa
D: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
E: malleomyces pseudomallei (aka burkholderia pseudomallei)
F: None of the above. | [B] |
<Instruct>: Given the context 'Protection against B. pseudomallei infection by anti-LPS, capsular polysaccharide and proteins has been short-lived, suggesting that antibody production offers limited protection in the initial stages of infection by an as-yet-undefined mechanism [12].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
B: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
C: burkholderia pseudomallei bdu 2
D: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
E: burkholderia pseudomallei (loefflerella pseudomallei) (aka burkholderia pseudomallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Protection against B. pseudomallei infection by anti-LPS, capsular polysaccharide and proteins has been short-lived, suggesting that antibody production offers limited protection in the initial stages of infection by an as-yet-undefined mechanism [12].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
B: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
C: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
D: burkholderia pseudomallei bdu 2
E: None of the above. | [E] |
<Instruct>: Given the context 'We have shown that following depletion of B220+ cells, survival rates decreased as much as 100% relative to non-depleted controls and individual CD4/CD8-depleted mice via the intraperitoneal route.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mice (aka mus sp.) (aka mus sp.)
B: eastern european house mouse (aka mus musculus musculus)
C: house mouse (aka mus musculus)
D: peromyscus
E: mus <subgenus> (mus (aka mus <subgenus>))
F: None of the above. | [C] |
<Instruct>: Given the context 'Results from C57BL/6 mice deficient in mature B-cells (μMT), CD4 T-cells (CD4-/-) or CD8 T-cells (CD8-/-) substantiate the requirement for B-cell involvement by evidence of μMT and CD4-/- decreased survival.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mice (aka mus sp.) (aka mus sp.)
B: mus musculus (house mouse) (aka mus musculus)
C: mus castaneus (aka mus musculus castaneus)
D: eastern european house mouse (aka mus musculus musculus)
E: mus <subgenus> (mus (aka mus <subgenus>))
F: None of the above. | [B] |
<Instruct>: Given the context 'In CD4-deficient mice, we have the additional potential variable that a CD4-dependent antibody response might also be inhibited during the vaccination phase relative to mice treated with antibody immediately prior to and during the early phases of infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: mouse (aka mus <genus>)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: peromyscus
F: None of the above. | [A] |
<Instruct>: Given the context 'Although not statistically significant, we did observe a decrease in survival in μMT (mature B cell) deficient mice as early as day 9 post challenge, whereas CD4-deficient mice produced similar results at day 32 post challenge, indicating a role for B cells independent of CD4 T cell help, perhaps through a T-independent mechanism of antibody production.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: eastern european house mouse (aka mus musculus musculus)
B: western european house mouse (aka mus musculus domesticus)
C: peromyscus
D: mus musculus (house mouse) (aka mus musculus)
E: mus (aka mus <genus>) (aka mus <genus>)
F: None of the above. | [D] |
<Instruct>: Given the context 'Although CD8-/- C57BL/6 demonstrated no decreased survival in our HK-vaccinated model, a lack of potential endogenous protein production by HK B. mallei may have contributed to limited MHC-I presentation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: acinetobacter mallei (aka burkholderia mallei)
B: malleomyces pseudomallei (aka burkholderia pseudomallei)
C: malleco
D: mallomonas peronoides (aka mallomonas peroneides)
E: erysiphe malloti
F: None of the above. | [A] |
<Instruct>: Given the context 'Complement associated studies revealed increased J774A.1 uptake of serum-treated B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: pseudomonas mallei (aka burkholderia mallei)
B: mucilaginibacter mallensis
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: malleco
E: erysiphe malloti
F: None of the above. | [A] |
<Instruct>: Given the context 'Complement-mediated uptake studies of B. pseudomallei by polymorphonuclear leukocytes (PMNs) suggest that capsule production contributes to resistance of phagocytosis by reducing C3b bacterial deposition', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: pseudomonas pseudomallei (aka burkholderia pseudomallei)
B: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
C: pseudomallei group
D: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
E: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
F: None of the above. | [A] |
<Instruct>: Given the context 'Previous studies have demonstrated that a polysaccharide capsule is present in B. mallei, [14,15] although in the present study enhanced uptake with serum-treated B. mallei was observed.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: inocybe subg. mallocybe (aka mallocybe)
B: erysiphe malloti
C: mallomonas papillosa
D: acinetobacter mallei (aka burkholderia mallei)
E: malleco
F: None of the above. | [D] |
<Instruct>: Given the context 'Previous reports have demonstrated the ability of B. mallei to survive within macrophage without the aid of serum coating organisms [16].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: modicella malleola (endogone malleola) (aka modicella malleola)
B: mucilaginibacter mallensis
C: malleco
D: loefferella mallei (aka burkholderia mallei)
E: mallomonas papillosa
F: None of the above. | [D] |
<Instruct>: Given the context 'The current results suggest that cobra venom factor treatment may affect the modulation of the immune response to B. mallei infection through B cell activation and/or memory B cell generation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleco
B: pfeifferella mallei (aka burkholderia mallei)
C: erysiphe malloti
D: mallomonas papillosa
E: inocybe subg. mallocybe (aka mallocybe)
F: None of the above. | [B] |
<Instruct>: Given the context 'The current results suggest that cobra venom factor treatment may affect the modulation of the immune response to B. mallei infection through B cell activation and/or memory B cell generation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: erysiphe malloti
B: malleco
C: inocybe subg. mallocybe (aka mallocybe)
D: mallomonas papillosa
E: None of the above. | [E] |
<Instruct>: Given the context 'Conclusion
In summary, our results provide a basis for future studies of protection via vaccination using either subunit or whole-organism vaccine preparations from lethal infection in the experimental BALB/c mouse model.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus molossinus (aka mus musculus molossinus)
B: mus musculus (house mouse) (aka mus musculus)
C: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
D: mus cricetus (aka cricetus cricetus)
E: western european house mouse (aka mus musculus domesticus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Understanding and defining the role of B cells in adaptive B. mallei immunity will likely be fundamental to the design of an efficacious vaccine and important goals of future research.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
B: mallomonas peronoides (aka mallomonas peroneides)
C: erysiphe malloti
D: malleco
E: loefferella mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Methods
Bacterial strain and mice
B. mallei strain ATCC 23344 (China 7) was cultured on Luria-Bertani agar supplemented with 4% glycerol (LB+4%G) agar plates for 48 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: actinobacillus mallei (aka burkholderia mallei)
B: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
C: malleomyces pseudomallei (aka burkholderia pseudomallei)
D: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
G: mouse (aka mus musculus)
H: mice (aka mus sp.) (aka mus sp.)
I: mus castaneus (aka mus musculus castaneus)
J: mucilaginibacter mallensis
K: None of the above. | [G; A] |
<Instruct>: Given the context 'Methods
Bacterial strain and mice
B. mallei strain ATCC 23344 (China 7) was cultured on Luria-Bertani agar supplemented with 4% glycerol (LB+4%G) agar plates for 48 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: 'bartonella melophagi' (aka bartonella melophagi)
B: house mouse (aka mus musculus)
C: mus cricetus (aka cricetus cricetus)
D: mouse (aka mus <genus>)
E: mucilaginibacter mallensis
F: malleco
G: pfeifferella mallei (aka burkholderia mallei)
H: malleomyces pseudomallei (aka burkholderia pseudomallei)
I: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
J: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
K: None of the above. | [B; G] |
<Instruct>: Given the context 'The absence of live B. mallei organisms in the HK preparations was confirmed after plating 10% of the total inoculums (v/v) and incubating these at 37°C for 48 h.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleco
B: malleomyces pseudomallei (aka burkholderia pseudomallei)
C: pfeifferella mallei (aka burkholderia mallei)
D: erysiphe malloti
E: mallomonas papillosa
F: None of the above. | [C] |
<Instruct>: Given the context 'Female, 6- to 8-week-old, BALB/c mice (n = 5–7) were obtained from Harlan Sprague Dawley, Inc. (Indianapolis, Indiana).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mouse (aka mus <genus>)
B: mus cricetus (aka cricetus cricetus)
C: mus <subgenus> (mus (aka mus <subgenus>))
D: mus musculus (house mouse) (aka mus musculus)
E: peromyscus
F: None of the above. | [D] |
<Instruct>: Given the context 'Female, 6- to 8-week-old, C57BL/6 mice deficient in mature B-cells (μMT), CD4 T-cells (CD4-/-) and CD8 T-cells (CD8-/-) and wild-type mice were obtained from The Jackson Laboratory (Bar Harbor, Maine).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: mouse (aka mus musculus)
C: mouse (aka mus <genus>)
D: mus sp. (mice (aka mus sp.))
E: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Vaccination and challenge
BALB/c and C57BL/6 mice were grouped and vaccinated with 0.5 μg of HK B. mallei (without adjuvant) by i.p. injection using a 25-gauge syringe.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mouse (aka mus <genus>)
B: peromyscus
C: mus (aka mus <subgenus>) (aka mus <subgenus>)
D: acinetobacter mallei (aka burkholderia mallei)
E: 'bartonella melophagi' (aka bartonella melophagi)
F: mus sp. (mice (aka mus sp.))
G: mucilaginibacter mallensis
H: malleco
I: modicella malleola (endogone malleola) (aka modicella malleola)
J: house mouse (aka mus musculus)
K: None of the above. | [J; D] |
<Instruct>: Given the context 'Vaccination and challenge
BALB/c and C57BL/6 mice were grouped and vaccinated with 0.5 μg of HK B. mallei (without adjuvant) by i.p. injection using a 25-gauge syringe.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: modicella malleola (endogone malleola) (aka modicella malleola)
B: western european house mouse (aka mus musculus domesticus)
C: mus castaneus (aka mus musculus castaneus)
D: erysiphe malloti
E: malleomyces pseudomallei (aka burkholderia pseudomallei)
F: mallomonas papillosa
G: mus (aka mus <subgenus>) (aka mus <subgenus>)
H: mus musculus (house mouse) (aka mus musculus)
I: mus cricetus (aka cricetus cricetus)
J: bacillus mallei (aka burkholderia mallei)
K: None of the above. | [H; J] |
<Instruct>: Given the context 'Two weeks post HK vaccination mice were injected i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: house mouse (aka mus musculus)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: mouse (aka mus <genus>)
D: eastern european house mouse (aka mus musculus musculus)
E: mus cricetus (aka cricetus cricetus)
F: None of the above. | [A] |
<Instruct>: Given the context 'with 2 × 107 CFU/100 μl of live B. mallei (~20 LD50)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: 'bartonella melophagi' (aka bartonella melophagi)
B: erysiphe malloti
C: malleco
D: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: None of the above. | [D] |
<Instruct>: Given the context 'Cell and cytokine depletions
Acute in vivo cell/cytokine depletion was performed with monoclonal rat anti-mouse CD4 (GK1.5), CD8α (53-6.7) or B220 (RA3-6B2) obtained from R&D Systems, Inc. (Minneapolis, MN) by methods similar to those we have previously described [19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mouse (aka mus musculus)
B: rattus norvegicus albus
C: rats (aka rattus sp.) (aka rattus sp.)
D: mice (aka mus sp.) (aka mus sp.)
E: rattus rattoides (aka rattus rattus)
F: peromyscus
G: mus norvegicus (aka rattus norvegicus)
H: eastern european house mouse (aka mus musculus musculus)
I: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
J: mus cricetus (aka cricetus cricetus)
K: None of the above. | [G; A] |
<Instruct>: Given the context 'Cell and cytokine depletions
Acute in vivo cell/cytokine depletion was performed with monoclonal rat anti-mouse CD4 (GK1.5), CD8α (53-6.7) or B220 (RA3-6B2) obtained from R&D Systems, Inc. (Minneapolis, MN) by methods similar to those we have previously described [19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus (aka mus <genus>) (aka mus <genus>)
B: rattus rattoides (aka rattus rattus)
C: mus cricetus (aka cricetus cricetus)
D: rattus norvegicus (rats (aka rattus norvegicus))
E: rattus norvegicus albus
F: rats (aka rattus sp.) (aka rattus sp.)
G: mice (aka mus sp.) (aka mus sp.)
H: mus musculus (house mouse) (aka mus musculus)
I: peromyscus
J: rattus (rats (aka rattus))
K: None of the above. | [D; H] |
<Instruct>: Given the context 'Functional grade purified rat anti-mouse interferon-gamma (IFN-γ, AN-18) was obtained from eBioscience (San Diego, CA) and purified anti-mouse tumor necrosis factor (TNF-α, MP6-XT3) from BD Pharmingen (San Diego, CA).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mouse (aka mus musculus)
B: rattus (rats (aka rattus))
C: rattus sp. (rats (aka rattus sp.))
D: mus cricetus (aka cricetus cricetus)
E: rattus norvegicus albus
F: mice (aka mus sp.) (aka mus sp.)
G: mus molossinus (aka mus musculus molossinus)
H: mice (aka mus <genus>) (aka mus <genus>)
I: rattus rattoides (aka rattus pyctoris)
J: mus norvegicus (aka rattus norvegicus)
K: None of the above. | [J; A] |
<Instruct>: Given the context 'Functional grade purified rat anti-mouse interferon-gamma (IFN-γ, AN-18) was obtained from eBioscience (San Diego, CA) and purified anti-mouse tumor necrosis factor (TNF-α, MP6-XT3) from BD Pharmingen (San Diego, CA).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus molossinus (aka mus musculus molossinus)
B: rattus rattoides (aka rattus rattus)
C: rattus sp. (rats (aka rattus sp.))
D: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
E: mus domesticus (aka mus musculus domesticus)
F: rat (aka rattus) (aka rattus)
G: brown rat (aka rattus norvegicus)
H: mouse (aka mus musculus)
I: rattus norvegicus albus
J: mus <subgenus> (mus (aka mus <subgenus>))
K: None of the above. | [G; H] |
<Instruct>: Given the context 'IFN-γ and TNF-α antibodies were injected i.p. 6 h prior to challenge, 200 μg per mouse in 200 μl PBS or at later time points as indicated.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mice (aka mus <genus>) (aka mus <genus>)
B: mus musculus (house mouse) (aka mus musculus)
C: mus molossinus (aka mus musculus molossinus)
D: peromyscus
E: mus cricetus (aka cricetus cricetus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Rat IgG isotype control was obtained from Southern Biotech (Birmingham, AL) and administered i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat]
<Options>: A: rattus norvegicus albus
B: rattus sp. (rats (aka rattus sp.))
C: house rat (aka rattus rattus)
D: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
E: rats (aka rattus norvegicus) (aka rattus norvegicus)
F: None of the above. | [E] |
<Instruct>: Given the context 'on day of challenge, 200 μg/mouse.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus (aka mus <subgenus>) (aka mus <subgenus>)
B: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
C: mus cricetus (aka cricetus cricetus)
D: house mouse (aka mus musculus)
E: mice (aka mus sp.) (aka mus sp.)
F: None of the above. | [D] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: norway rat (aka rattus norvegicus)
B: mus rattus (aka rattus rattus)
C: rattus rattoides (aka rattus pyctoris)
D: mouse (aka mus musculus)
E: mus molossinus (aka mus musculus molossinus)
F: mus cricetus (aka cricetus cricetus)
G: rattus (rats (aka rattus))
H: rattus norvegicus albus
I: mice (aka mus sp.) (aka mus sp.)
J: mus (aka mus <genus>) (aka mus <genus>)
K: None of the above. | [A; D] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus molossinus (aka mus musculus molossinus)
B: rats (aka rattus sp.) (aka rattus sp.)
C: mus sp. (mice (aka mus sp.))
D: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
E: rattus rattoides (aka rattus rattus)
F: mus domesticus (aka mus musculus domesticus)
G: rat (aka rattus) (aka rattus)
H: mus <subgenus> (mus (aka mus <subgenus>))
I: mouse (aka mus musculus)
J: rat (aka rattus norvegicus) (aka rattus norvegicus)
K: None of the above. | [J; I] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: rat (aka rattus norvegicus) (aka rattus norvegicus)
B: mus <subgenus> (mus (aka mus <subgenus>))
C: rat (aka rattus) (aka rattus)
D: mus sp. (mice (aka mus sp.))
E: rattus rattoides (aka rattus rattus)
F: rats (aka rattus sp.) (aka rattus sp.)
G: mus molossinus (aka mus musculus molossinus)
H: mus domesticus (aka mus musculus domesticus)
I: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
J: None of the above. | [A; J] |
<Instruct>: Given the context 'Complement depletion with cobra venom factor
Mice, six to seven per group, were vaccinated i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mouse (aka mus musculus)
B: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
C: mus castaneus (aka mus musculus castaneus)
D: mus (aka mus <subgenus>) (aka mus <subgenus>)
E: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
F: None of the above. | [A] |
<Instruct>: Given the context 'with 1 × 105 CFU of nonviable B. mallei cell preparation in a total volume of 0.1 ml.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces mallei (aka burkholderia mallei)
B: inocybe subg. mallocybe (aka mallocybe)
C: erysiphe malloti
D: mucilaginibacter mallensis
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: None of the above. | [A] |
<Instruct>: Given the context 'Two weeks later, 24 h and 1 h before challenge, complement depleted mice were treated i.p. with 12.5 units total cobra venom factor (Quidel Corporation Speciality Products, San Diego, CA) in 0.1 ml of PBS.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
B: mus <subgenus> (mus (aka mus <subgenus>))
C: mus musculus (house mouse) (aka mus musculus)
D: mus castaneus (aka mus musculus castaneus)
E: mus cricetus (aka cricetus cricetus)
F: None of the above. | [C] |
<Instruct>: Given the context 'Complement depletion was confirmed prior to challenge by micro-titer hemolytic complement activity (CH50) assay as previously described [20].
B. mallei J774A.1 uptake assays
J774A.1 cells were seeded (5 × 105) onto Corning costar 24 well plates (Corning, NY) with DMEM and incubated overnight at 37°C with 5% CO2.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mucilaginibacter mallensis
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
D: malleco
E: malleomyces pseudomallei (aka burkholderia pseudomallei)
F: None of the above. | [C] |
<Instruct>: Given the context 'Bacterial suspensions were incubated at 37°C for 45 minutes supplemented with 2% mouse serum from Sigma-Aldrich (St. Louis, MO.), heat inactivated mouse serum (56°C 30 minutes), or bacteria alone and then added at an MOI of 10:1 to J774A.1 cells in triplicate.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: eastern european house mouse (aka mus musculus musculus)
D: mouse (aka mus <genus>)
E: peromyscus
F: None of the above. | [A] |
<Instruct>: Given the context 'Antibodies used for analysis of surface markers included: FITC-conjugated rat anti-mouse CD45R/B220 (RA3-6B2, BD Pharmingen San Diego, CA) for B cells; FITC-conjugated rat anti-mouse CD8α (53-6.7) and CD4 (GK1.5, BD Pharmingen, San Diego, CA) for CD8+ or CD4+ cells, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mus musculus (house mouse) (aka mus musculus)
C: rattus rattus (rattus wroughtoni) (aka rattus rattus)
D: norway rat (aka rattus norvegicus)
E: rats (aka rattus) (aka rattus)
F: rattus norvegicus albus
G: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
H: mouse (aka mus <genus>)
I: rattus sp. (rats (aka rattus sp.))
J: western european house mouse (aka mus musculus domesticus)
K: None of the above. | [D; B] |
<Instruct>: Given the context 'Antibodies used for analysis of surface markers included: FITC-conjugated rat anti-mouse CD45R/B220 (RA3-6B2, BD Pharmingen San Diego, CA) for B cells; FITC-conjugated rat anti-mouse CD8α (53-6.7) and CD4 (GK1.5, BD Pharmingen, San Diego, CA) for CD8+ or CD4+ cells, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: western european house mouse (aka mus musculus domesticus)
B: house mouse (aka mus musculus)
C: mouse (aka mus <genus>)
D: mus molossinus (aka mus musculus molossinus)
E: rattus (rats (aka rattus))
F: mus cricetus (aka cricetus cricetus)
G: roof rat (aka rattus rattus)
H: rattus norvegicus albus
I: rattus sp. (rats (aka rattus sp.))
J: mus norvegicus (aka rattus norvegicus)
K: None of the above. | [J; B] |
<Instruct>: Given the context 'Samples evaluated for CD4+ and CD8α+ cells were also incubated with biotin-conjugated hamster anti-mouse CD3e (145-2C11) monoclonal antibody (BD Pharmingen, San Diego, CA) and subsequently with streptavidin APC Cy7.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: house mouse (aka mus musculus)
B: mus <subgenus> (mus (aka mus <subgenus>))
C: peromyscus
D: eastern european house mouse (aka mus musculus musculus)
E: mus molossinus (aka mus musculus molossinus)
F: None of the above. | [A] |
<Instruct>: Given the context 'Samples evaluated for CD4+ and CD8α+ cells were also incubated with biotin-conjugated hamster anti-mouse CD3e (145-2C11) monoclonal antibody (BD Pharmingen, San Diego, CA) and subsequently with streptavidin APC Cy7.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus molossinus (aka mus musculus molossinus)
B: peromyscus
C: eastern european house mouse (aka mus musculus musculus)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: None of the above. | [E] |
<Instruct>: Given the context 'Antibody assays
Immunoglobulin subclass IgG1 and IgG2a titers in mice were determined by a whole bacterial cell ELISA performed in 96-well, Immulon 2 HB, round-bottom plates (Dynex Technologies).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus (aka mus <subgenus>) (aka mus <subgenus>)
B: mouse (aka mus <genus>)
C: mus musculus (house mouse) (aka mus musculus)
D: peromyscus
E: mus castaneus (aka mus musculus castaneus)
F: None of the above. | [C] |
<Instruct>: Given the context 'B. mallei antigen was diluted in 0.1 M carbonate buffer (pH 9.5) and 50 μl of diluted cells placed into wells.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: actinobacillus mallei (aka burkholderia mallei)
B: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
C: mucilaginibacter mallensis
D: mallomonas peronoides (aka mallomonas peroneides)
E: malleco
F: None of the above. | [A] |
<Instruct>: Given the context 'The plates were washed with washing solution (1× PBS, 0.05% Tween 20), and incubated with 100 μl of blocking solution (1× PBS, 1% bovine serum albumin, 0.05% Tween 20) for 1 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bovine]
<Options>: A: domestic cow (aka bos taurus)
B: bos sp.
C: bos bubalis bubalis (aka bubalus bubalis bubalis)
D: cattle (aka bos)
E: bos taurus x bos indicus (aka bos indicus x bos taurus)
F: None of the above. | [A] |
<Instruct>: Given the context 'Dilutions of mouse sera were made with blocking solution in duplicate and plates were incubated for 1 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: peromyscus
C: eastern european house mouse (aka mus musculus musculus)
D: house mouse (aka mus musculus)
E: mice (aka mus <genus>) (aka mus <genus>)
F: None of the above. | [D] |
<Instruct>: Given the context 'Following incubation, plates were washed and 50 μl of anti-Ig-horseradish peroxidase subclass conjugate, diluted accordingly to manufacturer's instructions (Southern Biotechnology Associates, Inc.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [horseradish]
<Options>: A: rosa hugonis (rosa xanthina f. hugonis) (aka rosa hugonis)
B: rachis
C: horseradish (aka armoracia rusticana)
D: rosa horrida
E: rachiades
F: None of the above. | [C] |
<Instruct>: Given the context 'Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: candida/saccharomycetales (aka candida/saccharomycales clade)
B: saccharomyces sp.
C: saccharomyces lactis (aka kluyveromyces lactis)
D: saccharomyces cf. cerevisiae/paradoxus (saccharomyces cerevisiae or paradoxus) (aka saccharomyces cf. cerevisiae/paradoxus)
E: brewer's yeast (aka saccharomyces cerevisiae)
F: None of the above. | [E] |
<Instruct>: Given the context 'Abstract
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces cerevisiae x saccharomyces mikatae
B: mycoderma cerevisiae (aka saccharomyces cerevisiae)
C: saccharomyceta
D: candida/saccharomycetales (aka candida/saccharomycales clade)
E: saccharomyces lactis (aka kluyveromyces lactis)
F: None of the above. | [B] |
<Instruct>: Given the context 'A series of human X chromosome irradiation hybrids were mapped by this method, using a cosmid reference library for comparisons between overlapping hybrids to identify interesting clones for further analysis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: mammals (aka mammalia)
B: human (aka homo sapiens)
C: kingdom
D: homo (humans) (aka homo)
E: macrobiotus sapiens
F: None of the above. | [B] |
<Instruct>: Given the context 'Images
Nucleic Acids Research, Vol. 19, No. 12 3315
Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products
Anthony P.Monaco*, Veronica M.S.Lam2, Gunther Zehetner, Gregory G.Lennon, Christal Douglas, Dean Nizetic, Peter N.Goodfellow1 and Hans Lehrach
Genome Analysis Laboratory and 'Molecular Human Genetics Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK and 2Department of Biochemistry, Li Shu Fan Building, Sassoon Road, University of Hong Kong, Hong Kong
Received March 12, 1991; Revised and Accepted May 16, 1991
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883 (aka saccharomyces cerevisiae)
B: saccharomyces cf. cerevisiae
C: saccharomyceta
D: saccharomyces cerevisiae x saccharomyces mikatae
E: candida/saccharomycetales (aka candida/saccharomycales clade)
F: None of the above. | [A] |
<Instruct>: Given the context 'ABSTRACT
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomycodes
B: saccharomyces albicans (aka candida albicans)
C: saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883 (aka saccharomyces cerevisiae)
D: saccharomyces cf. cerevisiae/paradoxus (saccharomyces cerevisiae or paradoxus) (aka saccharomyces cf. cerevisiae/paradoxus)
E: true yeasts (aka saccharomycotina)
F: None of the above. | [C] |
<Instruct>: Given the context 'ABSTRACT
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomycodes
B: saccharomyces cf. cerevisiae/paradoxus (saccharomyces cerevisiae or paradoxus) (aka saccharomyces cf. cerevisiae/paradoxus)
C: saccharomyces albicans (aka candida albicans)
D: true yeasts (aka saccharomycotina)
E: None of the above. | [E] |
<Instruct>: Given the context 'A series of human X chromosome irradiation hybrids were mapped by this method, using a cosmid reference library for comparisons between overlapping hybrids to identify interesting clones for further analysis.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: species
B: humans (aka homo)
C: suborder
D: homo sapiens (human) (aka homo sapiens)
E: macrobiotus sapiens
F: None of the above. | [D] |
<Instruct>: Given the context 'INTRODUCTION
The generation of human DNA probes specific for individual chromosomes and subregions of chromosomes has been advanced with Alu-sequence primed polymerase chain reaction amplification (Alu-PCR, 1-3).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: genus
B: species
C: homo sapiens (human) (aka homo sapiens)
D: mammals (aka mammalia)
E: eutherian mammals (aka eutheria)
F: None of the above. | [C] |
<Instruct>: Given the context 'This method specifically amplifies sequences between Alu repeats from human DNA in somatic cell hybrids and yeast artificial chromosomes (YACs, 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; yeast]
<Options>: A: baker's yeast (aka saccharomyces cerevisiae)
B: saccharomyces sp.
C: genus
D: saccharomycodes
E: this
F: saccharomyces cerevisiae x saccharomyces mikatae
G: suborder
H: saccharomyces lactis (aka kluyveromyces lactis)
I: avian (aka aves)
J: human (aka homo sapiens)
K: None of the above. | [J; A] |
<Instruct>: Given the context 'This method specifically amplifies sequences between Alu repeats from human DNA in somatic cell hybrids and yeast artificial chromosomes (YACs, 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; yeast]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: saccharomyces cerevisiae (saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883) (aka saccharomyces cerevisiae)
C: saccharomycetes (hemiascomycetes) (aka saccharomycetes)
D: probles
E: this
F: homo (humans) (aka homo)
G: macrobiotus sapiens
H: saccharomyces lactis (aka kluyveromyces lactis)
I: candida/saccharomycetales (aka candida/saccharomycales clade)
J: saccharomyces cf. cerevisiae
K: None of the above. | [A; B] |
<Instruct>: Given the context 'Two new human specific Alu primers were used to generate DNA probes from a series of irradiation-reduced hybrids containing multiple human X chromosome fragments of 1-2000 kb on a hamster chromosome background (5; P.N.G., unpublished).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: humans (aka homo)
B: mammals (aka mammalia)
C: primate (aka primates)
D: human (aka homo sapiens)
E: probles
F: None of the above. | [D] |
<Instruct>: Given the context 'The Alu-PCR products were hybridized as a pool of probes to X-specific cosmid and YAC libraries, after
competitive reassociation with an excess of human DNA to both the library filters and radioactively labelled Alu-PCR products.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: biota (aka cellular organisms)
C: humans (aka homo)
D: homo sapiens (human) (aka homo sapiens)
E: primate (aka primates)
F: None of the above. | [D] |
<Instruct>: Given the context 'METHODS
Two human Alu sequence primers were generated which were shown to be human specific; 3144 from the 3' end of Alu: 5'-GAGCGAGACTCCGTCTCAAA-3' and 2729 from the 5' end of Alu: 5'-GTGGATCACCTGAGGTCAGGAGTTC-3'.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: macrobiotus sapiens
B: species
C: homo sapiens (human) (aka homo sapiens)
D: suborder
E: cellular organisms (biota) (aka cellular organisms)
F: None of the above. | [C] |
<Instruct>: Given the context 'Chinese hamster DNA and no DNA PCR reactions were done to control for non-human products (data not shown).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [chinese hamster; human]
<Options>: A: romanian hamster (aka mesocricetus newtoni)
B: armenian hamster (aka nothocricetulus migratorius)
C: macrobiotus sapiens
D: ciscaucasian hamster (aka mesocricetus raddei)
E: golden hamsters (aka mesocricetus auratus)
F: biota (aka cellular organisms)
G: chinese hamsters (aka cricetulus griseus)
H: species
I: mammals (aka mammalia)
J: human (aka homo sapiens)
K: None of the above. | [G; J] |
<Instruct>: Given the context 'Chinese hamster DNA and no DNA PCR reactions were done to control for non-human products (data not shown).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [chinese hamster; human]
<Options>: A: animals (aka metazoa)
B: species
C: ciscaucasian hamster (aka mesocricetus raddei)
D: mammals (aka mammalia)
E: hamsters (aka cricetinae)
F: romanian hamster (aka mesocricetus newtoni)
G: gansu hamster (aka cansumys canus)
H: chinese hamster (aka cricetulus griseus)
I: genus
J: human (aka homo sapiens)
K: None of the above. | [H; J] |
<Instruct>: Given the context 'The radioactively labelled pool of fragments was prehybridized with 37.5 ,^g of total human DNA and 12.5 tsg of hamster DNA immobilized on a cellulose support matrix, prepared as previously described (7).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: biota (aka cellular organisms)
B: macrobiotus sapiens
C: human (aka homo sapiens)
D: genus
E: suborder
F: None of the above. | [C] |
<Instruct>: Given the context 'I I
Figur 2a and 2b: Hybridization of Alu-PCR products generated with Alu primer 3144 from irradiation hybrid 48 to duplicate copies of 22 x22cm filters containing 9216 human X chromosome cosmids (8).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: mammals (aka mammalia)
C: primate (aka primates)
D: birds (aka aves)
E: suborder
F: None of the above. | [A] |
<Instruct>: Given the context 'Figure 1: A schematic diagram of the human X chromosome alongside the approximate cytogenetic location of fragments identified in nine irradiation hybrids (numbers across the top).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: macrobiotus sapiens
B: placental mammals (aka eutheria)
C: kingdom
D: genus
E: homo sapiens (human) (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'The human X fragments were identified by hybridization of 27 known DNA markers (indicated by a black line; P.N.G, unpublished) or by cosmids in common with unique X chromosome probes in the reference library database (open boxes and Table 1).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: probles
C: eutherian mammals (aka eutheria)
D: mammals (aka mammalia)
E: homo sapiens (human) (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'denatured and sheared total human DNA in 50% formamide, 4XSSC, 0.05 M sodium phosphate pH 7.2, 0.001 M EDTA, 10% dextran sulphate, 1.0% SDS, 50 isg/ml denatured salmon sperm DNA and OxDenhardt's solution.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: primate (aka primates)
B: homo sapiens (human) (aka homo sapiens)
C: suborder
D: kingdom
E: mammals (aka mammalia)
F: None of the above. | [B] |
<Instruct>: Given the context 'The radioactively labelled Alu-PCR products were denatured and added to fresh
hybridization solution without human DNA competitor at 1 x 106
cpm/ml and hybridized at 42?C for 16 hours.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: species
B: macrobiotus sapiens
C: homo sapiens (human) (aka homo sapiens)
D: probles
E: birds (aka aves)
F: None of the above. | [C] |
<Instruct>: Given the context 'For each hybridization, two sets of duplicate cosmid filters were used from the ICRF reference library system (8), each containing 9216 flow-sorted human X chromosome cosmid clones or approximately 2 chromosome equivalents on a 22 x 22 cm filter (9).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: mammals (aka mammalia)
C: biota (aka cellular organisms)
D: this
E: homo (humans) (aka homo)
F: None of the above. | [A] |
<Instruct>: Given the context 'For each hybridization, two sets of duplicate cosmid filters were used from the ICRF reference library system (8), each containing 9216 flow-sorted human X chromosome cosmid clones or approximately 2 chromosome equivalents on a 22 x 22 cm filter (9).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: mammals (aka mammalia)
B: biota (aka cellular organisms)
C: this
D: homo (humans) (aka homo)
E: None of the above. | [E] |
<Instruct>: Given the context 'RESULTS
A panel of 195 X chromosome irradiation hybrids was constructed (50,000 rads) and characterized by DNA hybridization using 27 X chromosome markers and flourescence in situ hybridization using total human DNA as probe (Benham et al., 1989; P.N.G., unpublished).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: macrobiotus sapiens
C: suborder
D: human (aka homo sapiens)
E: eutherian mammals (aka eutheria)
F: None of the above. | [D] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.